Cannara Biotech's record Q1 results and expected melt-up to low $2 range.
LOVE.V — LONG The author argues Cannara Biotech will melt up and establish a base in the low $2 range. They cite record Q1 results with $1M net income and attribute the YoY decline to likely Q4 executive compensation. The market's positive reaction supports the view.
This will melt up and establish a base in the low $2 range IMO
This Reddit post, published January 26, 2026, features u/NoOcelot discussing LOVE.V. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/NoOcelot · Tickers: LOVE.V